VistaGen Therapeutics, Inc. (VTGN)

NASDAQ: VTGN · IEX Real-Time Price · USD

4.720

-0.110 (-2.28%)

At close: Apr 24, 2024, 4:00 PM

4.870

+0.150 (3.18%)

After-hours: Apr 24, 2024, 6:22 PM EDT

VistaGen Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 2010
Cash & Equivalents	16.64	68.14	103.11	1.36	13.1	10.38	2.92	0.43	0.07	0	Upgrade
Cash & Cash Equivalents	16.64	68.14	103.11	1.36	13.1	10.38	2.92	0.43	0.07	0	Upgrade
Cash Growth	-75.58%	-33.92%	7508.91%	-89.66%	26.23%	255.26%	581.75%	512.14%	-	-	Upgrade
Receivables	0	0	0	0	0.3	0	0	0	0	0	Upgrade
Other Current Assets	0.87	2.86	1.01	0.23	0.23	0.64	0.46	0.43	0.04	0.04	Upgrade
Total Current Assets	17.51	71	104.12	1.58	13.63	11.02	3.38	0.86	0.11	0.04	Upgrade
Property, Plant & Equipment	2.77	3.08	3.59	3.79	0.31	0.21	0.29	0.09	0.12	0.18	Upgrade
Other Long-Term Assets	0.81	0.57	0.58	0.4	0.07	0.05	0.05	0.05	0.05	0.05	Upgrade
Total Long-Term Assets	3.58	3.65	4.16	4.19	0.38	0.26	0.33	0.13	0.16	0.22	Upgrade
Total Assets	21.09	74.64	108.28	5.77	14.01	11.28	3.71	0.99	0.27	0.26	Upgrade
Accounts Payable	2.47	2.76	0.84	1.84	1.06	1.2	0.87	0.94	2.25	2.44	Upgrade
Deferred Revenue	3.03	2.8	3.91	0	0	0	0	0	0	0	Upgrade
Current Debt	0.59	0.43	0.37	0.37	0.06	0.06	0.06	0.04	13.93	2.13	Upgrade
Other Current Liabilities	-1.53	-0.23	-0.93	0.56	1.69	0.21	0.44	0.81	1.21	0.63	Upgrade
Total Current Liabilities	4.57	5.77	4.19	2.77	2.8	1.46	1.37	1.79	17.39	5.21	Upgrade
Long-Term Debt	2.13	2.61	3.35	3.72	0.01	0.01	0.01	0.03	0.33	4.79	Upgrade
Other Long-Term Liabilities	2.31	1.56	8.76	5.01	4.13	2.89	1.72	2.15	3.09	3.07	Upgrade
Total Long-Term Liabilities	4.44	4.16	12.11	8.73	4.14	2.9	1.73	2.17	3.42	7.86	Upgrade
Total Liabilities	9.01	9.93	16.3	11.5	6.94	4.36	3.1	3.97	20.81	13.06	Upgrade
Total Debt	2.72	3.04	3.72	4.09	0.07	0.07	0.07	0.07	14.26	6.92	Upgrade
Debt Growth	-10.49%	-18.28%	-9.12%	6043.84%	1.22%	-4.78%	-3.89%	-99.50%	106.14%	29.39%	Upgrade
Retained Earnings	-326.85	-267.6	-219.84	-201.91	-181.13	-156.54	-142	-131.74	-84.52	-70.64	Upgrade
Shareholders' Equity	12.08	64.72	91.98	-5.73	7.08	6.92	0.62	-2.98	-20.54	-12.8	Upgrade
Net Cash / Debt	13.92	65.1	99.39	-2.74	13.03	10.31	2.85	0.36	-14.19	-6.92	Upgrade
Net Cash / Debt Growth	-78.62%	-34.50%	-	-	26.39%	261.56%	699.83%	-	-	-	Upgrade
Net Cash Per Share	2.00	9.86	34.62	-	13.69	22.27	11.36	6.05	-	-	Upgrade
Working Capital	12.94	65.23	99.93	-1.19	10.83	9.56	2.01	-0.94	-17.28	-5.17	Upgrade
Book Value Per Share	1.74	9.81	32.04	-3.58	7.43	14.94	2.45	-50.52	-418.24	-328.74	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).